{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:04:01Z","timestamp":1768320241727,"version":"3.49.0"},"reference-count":31,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":3574,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective was to evaluate the effect of a HPV vaccination program on the incidence proportion of a proxy, genital warts (GW), in women in France. Methods: The number of primary GW cases was prospectively recorded over two 4-month periods before (T0: Dec 2008 to March 2009) and after (T1: Dec 2011 to March 2012) a HPV vaccination program. A total of 160 gynaecologists participated in T0 and 189 in T1. Primary genital herpes (HSV) infection was used as a control. Results: During T0, 39 190 15- to 26 year-old women were seen, of whom 176 were diagnosed with GW (incidence proportion: 0.45%) and 155 with primary HSV infection (incidence proportion: 0.39%). During T1, 45 628 females were seen [229 with GW (incidence proportion: 0.50%) and 202 with HSV (incidence proportion: 0.44%)]. In the 15\u201320 years age category, the incidence proportion of primary GW decreased from 0.41% to 0.30% (P = 0.128) between T0 and T1, and the proportion of women newly diagnosed with primary genital herpes diseases slightly increased from 0.34% to 0.38% (P = 0.620). In the 15\u201318 years age group, this decrease became significant (0.34% to 0.18%; P = 0.048). Conclusions: A trend for a non-significant decreased incidence proportion of GW was observed in young women below 20 years who are more frequently vaccinated. This may be the result of HPV vaccination and suggests that a substantial increase in vaccine coverage could lead to a more pronounced decreased incidence proportion of GW in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh14218","type":"journal-article","created":{"date-parts":[[2015,11,15]],"date-time":"2015-11-15T18:35:14Z","timestamp":1447612514000},"page":"49-54","source":"Crossref","is-referenced-by-count":3,"title":["Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study): a multicentric prospective observational study"],"prefix":"10.1071","volume":"13","author":[{"given":"Philippe","family":"Judlin","sequence":"first","affiliation":[{"name":"AP\u00f4le de Gyn\u00e9cologie, Obst\u00e9trique et Reproduction, Maternit\u00e9 r\u00e9gionale universitaire de Nancy, 10, rue du Dr Heydenreich \u2013\u00a0CS 74213-54 042 Nancy Cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Carole","family":"Jacquard","sequence":"additional","affiliation":[{"name":"BSanofi Pasteur MSD, 8, rue Jonas Salk, 69367 Lyon Cedex 07, France."},{"name":"JCorresponding author. Email: ACJacquard@spmsd.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Carcopino","sequence":"additional","affiliation":[{"name":"CDepartment of Obstetrics and Gynaecology, Assistance Publique des H\u00f4pitaux de Marseille (APHM), H\u00f4pital Nord, Chemin des Bourrely, 13915 Marseille cedex 20, France."},{"name":"DAix-Marseille Universit\u00e9 (AMU), University of Medicine, 51, Boulevard Pierre Dramard 13916 Marseille cedex 20, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Aubin","sequence":"additional","affiliation":[{"name":"EEA3181, SFR FED 4234, Universit\u00e9 de Franche-Comt\u00e9, B\u00e2timent INSERM, 20 rue Fran\u00e7oise Dolto, 25000 Besan\u00e7on, France."},{"name":"FDermatology Department, University Hospital, 3, boulevard Fleming, 25000 Besan\u00e7on, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Dahlab","sequence":"additional","affiliation":[{"name":"BSanofi Pasteur MSD, 8, rue Jonas Salk, 69367 Lyon Cedex 07, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mistretta","sequence":"additional","affiliation":[{"name":"GRCTS, 38 Rue du Plat, 69002 Lyon, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Not","sequence":"additional","affiliation":[{"name":"GRCTS, 38 Rue du Plat, 69002 Lyon, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Boelle","sequence":"additional","affiliation":[{"name":"HFacult\u00e9 de M\u00e9decine Pierre et Marie Curie, INSERM UMR S707, APHP, 27, rue de Chaligny, 75571 Paris, Cedex 12, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Aynaud","sequence":"additional","affiliation":[{"name":"IDermatology Department, University Hospital Cochin, 89, rue d\u2019Assas, 75006 Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Soubeyrand","sequence":"additional","affiliation":[{"name":"BSanofi Pasteur MSD, 8, rue Jonas Salk, 69367 Lyon Cedex 07, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"2025102617120668500_R1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).","volume":"2","author":"Dayyani","year":"2010","journal-title":"Head Neck Oncol"},{"key":"2025102617120668500_R2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"2025102617120668500_R3","doi-asserted-by":"crossref","first-page":"c1439","DOI":"10.1136\/bmj.c1439","article-title":"Oropharyngeal carcinoma related to human papillomavirus.","volume":"340","author":"Mehanna","year":"2010","journal-title":"BMJ Clin Res"},{"key":"2025102617120668500_R4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma.","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"2025102617120668500_R5","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2025102617120668500_R6","first-page":"91","article-title":"Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia.","volume":"16","author":"Potocnik","year":"2007","journal-title":"Acta Dermatovenerol Alp Panmonica Adriat"},{"key":"2025102617120668500_R7","first-page":"107","article-title":"[Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France].","volume":"35","author":"Monsonego","year":"2007","journal-title":"Gynecol Obstet Fertil"},{"key":"2025102617120668500_R8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"2025102617120668500_R9","first-page":"129","article-title":"2013 vaccination schedule and recommendations from the \u201cHaut Conseil de la sant\u00e9 publique\u201d in France.","volume":"14\u201315","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2013","journal-title":"BEH"},{"key":"2025102617120668500_R10","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1016\/j.vaccine.2011.02.064","article-title":"HPV vaccination in France: uptake, costs and issues for the National Health Insurance.","volume":"29","author":"Fagot","year":"2011","journal-title":"Vaccine"},{"key":"2025102617120668500_R11","first-page":"72","article-title":"Estimation des couvertures vaccinales en France \u00e0 partir de l\u2019\u00c9chantillon g\u00e9n\u00e9raliste des b\u00e9n\u00e9ficiaires (EGB): exemples de la rougeole, de l\u2019h\u00e9patite B et de la vaccination HPV.","volume":"8\u20139","author":"Fonteneau","year":"2013","journal-title":"BEH"},{"key":"2025102617120668500_R12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ejogrb.2013.07.028","article-title":"HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of Cote d\u2019Or.","volume":"170","author":"Bertaut","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025102617120668500_R13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.respe.2013.04.005","article-title":"Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors.","volume":"61","author":"Ganry","year":"2013","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2025102617120668500_R14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jgyn.2011.10.001","article-title":"[HPV prophylactic vaccine coverage in France: results of a survey among high school and university students in Marseilles\u2019 area].","volume":"41","author":"Sabiani","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2025102617120668500_R15","unstructured":"Health Protection Agency. Trends in anogenital warts and anogenital herpes simplex virus infection in the United Kingdom: 1996 to 2005. CDR Weekly 2006; 16 (48): 1\u20134. Available online at: http:\/\/webarchive.nationalarchives.gov.uk\/+\/http:\/\/www.hpa.org.uk\/cdr\/archives\/2006\/cdr4806.pdf [verified January 2014]."},{"key":"2025102617120668500_R16","unstructured":"European Medicines Agency. Gardasil \u2013 summary of product characteristics (Updated November 2013). Available online at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000703\/WC500021142.pdf [verified March 2014]."},{"key":"2025102617120668500_R17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bmj.38726.404120.7C","article-title":"Trends in sexually transmitted infections in general practice 1990\u20132000: population based study using data from the UK general practice research database.","volume":"332","author":"Cassell","year":"2006","journal-title":"BMJ Clin Res Ed"},{"key":"2025102617120668500_R18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"2025102617120668500_R19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/sti.2008.030999","article-title":"Epidemiology and costs associated with genital warts in Canada.","volume":"85","author":"Marra","year":"2009","journal-title":"Sex Transm Infect"},{"key":"2025102617120668500_R20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1684\/bdc.2011.1454","article-title":"Evolution of sexual behaviour in France and emergence of new head and neck cancers.","volume":"98","author":"Veluire","year":"2011","journal-title":"Bull Cancer"},{"key":"2025102617120668500_R21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.arcped.2013.03.002","article-title":"Contraception and adolescence].","volume":"20","author":"Amate","year":"2013","journal-title":"Arch Pediatr"},{"key":"2025102617120668500_R22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination.","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"key":"2025102617120668500_R23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010.","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"2025102617120668500_R24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jadohealth.2013.09.018","article-title":"Population impact of HPV vaccines: summary of early evidence.","volume":"53","author":"Hariri","year":"2013","journal-title":"J Adolesc Health"},{"key":"2025102617120668500_R25","first-page":"f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ Clin Res"},{"key":"2025102617120668500_R26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"2025102617120668500_R27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2025102617120668500_R28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"2025102617120668500_R29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/OLQ.0b013e3182756efd","article-title":"Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.","volume":"40","author":"Mikolajczyk","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2025102617120668500_R30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.33321\/cdi.2008.32.45","article-title":"Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia.","volume":"32","author":"Brotherton","year":"2008","journal-title":"Commun Dis Intell Q Rep"},{"key":"2025102617120668500_R31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/3-540-36583-4_7","article-title":"Mass vaccination against hepatitis B: the French example.","volume":"304","author":"Denis","year":"2006","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/13\/1\/49\/1255171\/sh14218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/13\/1\/49\/1255171\/sh14218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:12:13Z","timestamp":1761513133000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/13\/1\/49\/184967\/Potential-impact-of-the-human-papillomavirus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2,11]]}},"URL":"https:\/\/doi.org\/10.1071\/sh14218","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]}}}